Medical Health Cluster

Hepatitis B

Age Range Is Expanded for Universal Hepatitis B Vaccination

An update from the CDC’s Advisory Committee on Immunization Practices (ACIP) is intended to boost low hepatitis B vaccination rates and decrease disease cases among adults aged 19 to 59 years. James Cavallini/ Instead of screening this age group for vaccination based on risk factors such as injection drug use, having multiple […]

Read More

EMA Recommends PreHevbri Hepatitis B Vaccine for Approval

The European Medicines Agency’s (EMA’s) human medicines committee has recommended approval of a hepatitis B vaccine for adults. The agency’s Committee for Medicinal Products for Human Use (CHMP) granted a positive opinion for PreHevbri on February 24 for active immunization against hepatitis B virus (HBV) infection. PreHevbri (PreHevBrio in the United States and Sci-B-Vac […]

Read More